J&J COVID vaccine effective against Delta variant
July 2, 2021Medical Communications
Johnson & Johnson (J&J) has reported that its single-dose Covid-19 vaccine stimulated robust, continued neutralising antibody activity against the Delta …
Travellers with Indian-made AZ jab may face European ban
July 2, 2021Medical Communications COVID-19, India, Vaccine
Up to 5 million Britons planning to travel to Europe may face a travel ban if they have been vaccinated …
Origin Group launches fully recyclable sachet for health sector
July 2, 2021Medical Communications
The Origin Group has launched a 100% recyclable single-dose sachet which is fully brandable for the health sector. The new …
CureVac vaccine shows only 48% efficacy
July 1, 2021CureVac’s COVID-19 vaccine has shown only 48% efficacy in its final analysis. This result is only marginally better than the …
Birmingham University & Nonacus to develop urine test for bladder cancer
July 1, 2021bladder cancer, cfdna, oncology
The University of Birmingham has partnered with Nonacus to develop a non-invasive test for bladder cancer. The test, which is …
Booster jabs planned for over 50s from September
July 1, 2021The NHS is planning to offer COVID-19 booster shots to over 50s from September. A third shot of the vaccine …
A study has found that COVID-19 is common in pet cats and dogs
July 1, 2021A study has found that COVID-19 is common in pet cats and dogs whose owners have the disease. Samples were …
PrecisionLife appoints Ray Pawlicki as Executive Chair to the board of directors
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
PrecisionLife Limited has appointed Ray Pawlicki, previously CIO at Biogen and Novartis, as Executive Chair to the board of directors.Widely …
New Chief Operating Officer for Dutch MedTech STENTiT
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Medical device company STENTiT has appointed Dr Golo von Basum as its Chief Operating Officer.He will be responsible for the …
Christian Dillon announced as Vice President of Biology at PhoreMost
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
PhoreMost has announced the appointment of Dr Christian Dillon as Vice President of Biology.In this new role, Dr Dillon will …
Ashfield Engage appoints new Head of Patient Solutions
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Ashfield Engage, part of UDG Healthcare plc, has appointed Serap Becker as Head of Patient Solutions for the DACH region.Joining …
Personalised medicine in oncology: Where are we now?
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery
The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …
Novartis appoints Alessandra Dorigo as General Manager
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Alessandra Dorigo has been appointed as the new General Manager UK, Ireland, Baltics, and Nordics for Novartis Advanced Accelerator Applications …
Exploring the potential of drug repurposing
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug repurposing
Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …
“Worst drug approval decision in recent US history”
June 30, 2021Research and Development
The FDA’s decision to accelerate approval for Aduhelm, the first new drug for Alzheimer’s in two decades, has been met …
Sickle cell therapy granted innovation passport by MHRA
June 30, 2021Research and Development MHRA, SCD, brexit
Bluebird bio has been granted an innovation passport, under the new UK approval process, for LentiGlobin (bb1111) a promising treatment …
EU approves BMS’s treatment for metastatic colorectal cancer
June 30, 2021Research and Development
The EU has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the treatment of metastatic colorectal cancer. The treatment will be …
RNA breakthrough: Fluorescence used to track molecule movement
June 30, 2021Research and Development AstraZeneca, RNA, mrna
Researchers at Chalmers University of Technology in Sweden have announced a breakthrough in the labelling method of messenger RNA (mRNA) …
EU approves Merck’s treatment for oesophageal cancer
June 30, 2021Research and Development
The EU has approved Merck’s KEYTRUDA, in combination with platinum- and fluoropyrimidine-based chemotherapy, as treatment for advanced oesophageal cancer. The …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
